RBC Capital analyst Conor McNamara maintains QuidelOrtho (NASDAQ:QDEL) with a Outperform and lowers the price target from $81 to $68.
RBC Capital Maintains Outperform on QuidelOrtho, Lowers Price Target to $68
Company Profile